CN105121652B - 用于在酵母和其它转化细胞中高产量表达多肽的温度变动法 - Google Patents

用于在酵母和其它转化细胞中高产量表达多肽的温度变动法 Download PDF

Info

Publication number
CN105121652B
CN105121652B CN201480014647.8A CN201480014647A CN105121652B CN 105121652 B CN105121652 B CN 105121652B CN 201480014647 A CN201480014647 A CN 201480014647A CN 105121652 B CN105121652 B CN 105121652B
Authority
CN
China
Prior art keywords
antibody
temperature
promoters
yeast
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480014647.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN105121652A (zh
Inventor
G·莱斯尼基
P·D·麦克内尔
F·哈特内尔
M·杨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Lundbeck Seattle Biopharmaceuticals Inc
Original Assignee
Alder Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alder Biopharmaceuticals Inc filed Critical Alder Biopharmaceuticals Inc
Publication of CN105121652A publication Critical patent/CN105121652A/zh
Application granted granted Critical
Publication of CN105121652B publication Critical patent/CN105121652B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • C07K16/248IL-6
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Analytical Chemistry (AREA)
CN201480014647.8A 2013-03-15 2014-03-17 用于在酵母和其它转化细胞中高产量表达多肽的温度变动法 Active CN105121652B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361790613P 2013-03-15 2013-03-15
US201361791471P 2013-03-15 2013-03-15
US61/790,613 2013-03-15
US61/791,471 2013-03-15
PCT/US2014/030453 WO2014145650A1 (en) 2013-03-15 2014-03-17 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells

Publications (2)

Publication Number Publication Date
CN105121652A CN105121652A (zh) 2015-12-02
CN105121652B true CN105121652B (zh) 2020-07-28

Family

ID=51538058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480014647.8A Active CN105121652B (zh) 2013-03-15 2014-03-17 用于在酵母和其它转化细胞中高产量表达多肽的温度变动法

Country Status (15)

Country Link
US (2) US10138294B2 (https=)
EP (2) EP2971037B1 (https=)
JP (1) JP6412552B2 (https=)
KR (1) KR102202477B1 (https=)
CN (1) CN105121652B (https=)
AU (1) AU2014232813B2 (https=)
CA (1) CA2905180C (https=)
DK (1) DK2971037T3 (https=)
ES (2) ES3057435T3 (https=)
IL (1) IL241176B (https=)
MX (2) MX366647B (https=)
SG (1) SG11201506034TA (https=)
TW (1) TWI636136B (https=)
WO (1) WO2014145650A1 (https=)
ZA (1) ZA201505483B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10202630B2 (en) * 2013-03-15 2019-02-12 Alderbio Holdings Llc Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
PE20161439A1 (es) 2014-03-21 2017-01-26 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
JP2018501814A (ja) 2014-11-11 2018-01-25 クララ フーズ カンパニー 卵白タンパク質産生のための方法および組成物
JP2017045865A (ja) 2015-08-26 2017-03-02 ルネサスエレクトロニクス株式会社 半導体装置およびその製造方法
CN106191181B (zh) * 2016-07-22 2019-12-13 江苏江山聚源生物技术有限公司 一种毕赤酵母表达重组蛋白的发酵工艺
WO2018055574A1 (en) 2016-09-23 2018-03-29 Teva Pharmaceuticals International Gmbh Treating refractory migraine
EP3592800A4 (en) 2017-03-10 2021-01-06 Bolt Threads, Inc. COMPOSITIONS AND METHODS OF PRODUCING HIGHLY SECRETED YIELD OF RECOMBINANT PROTEIN
KR20250121449A (ko) 2017-03-10 2025-08-12 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법
IL277352B2 (en) * 2018-03-16 2025-08-01 Genzyme Corp Methods for improving cell viability in a production bioreactor
US10221403B1 (en) * 2018-04-25 2019-03-05 Life Rainbow Biotech Co., Ltd. Method of preparing zearalenone hydrolase
CN108546637A (zh) * 2018-05-23 2018-09-18 华东理工大学 重组毕赤酵母表达葡萄糖氧化酶发酵装置以及发酵培养方法
MX2021000053A (es) * 2018-07-12 2021-03-25 Amyris Inc Metodos para controlar velocidades de alimentacion de la fermentacion.
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
BR112022000545A2 (pt) 2019-07-11 2022-04-05 Clara Foods Co Composições de proteína e produtos de consumo destas
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
FI4055177T3 (fi) * 2019-11-08 2024-10-31 Danisco Us Inc Parantuneen proteiinituottavuuden fenotyyppejä käsittäviä sienikantoja ja menetelmiä niitä varten
WO2021146233A1 (en) 2020-01-14 2021-07-22 Basf Se Method for producing recombinant protein in yeast cells
US20250207158A1 (en) * 2022-03-24 2025-06-26 Versalis S.P.A. Fermentation process for the production of lipids from oleaginous yeasts
EP4594342A2 (en) * 2022-09-29 2025-08-06 Antheia, Inc. Methods of improving production of morphinan alkaloids and derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221630B1 (en) * 1999-03-24 2001-04-24 The Penn State Research Foundation High copy number recombinant expression construct for regulated high-level production of polypeptides in yeast
WO2011075686A2 (en) * 2009-12-18 2011-06-23 Ventria Bioscience Methods & compositions comprising heat shock proteins

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
WO1994021293A1 (en) 1993-03-19 1994-09-29 Duke University Method of treatment of tumors with an antibody binding to tenascin
ES2251723T3 (es) 1994-08-12 2006-05-01 Immunomedics, Inc. Inmunoconjugados y anticuerpos humanizados especificos para linfoma de celulas b y celulas de leucemia.
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US6730499B1 (en) 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
PT1678314E (pt) 2003-10-22 2012-11-27 Keck Graduate Inst Métodos de síntese de polipéptidos heteromultiméricos em levedura utilizando uma estratégia de conjugação haplóide
DK2021463T3 (en) 2006-05-19 2017-01-16 Alder Biopharmaceuticals Inc Culture method to obtain a cloned population of antigen-specific B cells
HUE032563T2 (en) 2007-05-21 2017-09-28 Alderbio Holdings Llc Antibodies to IL-6 and their use
KR20170036814A (ko) 2007-05-21 2017-04-03 앨더바이오 홀딩스 엘엘씨 신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
US20090269832A1 (en) 2007-11-05 2009-10-29 Modular Genetics, Inc. Growth of Microorganisms in Media Containing Crude Glycerol
US8501449B2 (en) 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US10150968B2 (en) 2011-08-19 2018-12-11 Alderbio Holdings Llc Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
EP2744903B1 (en) 2011-08-19 2018-10-10 AlderBio Holdings LLC Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
US10202630B2 (en) * 2013-03-15 2019-02-12 Alderbio Holdings Llc Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
US10189892B2 (en) * 2013-03-15 2019-01-29 Alderbio Holdings Llc Fermentation process for antibody production

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221630B1 (en) * 1999-03-24 2001-04-24 The Penn State Research Foundation High copy number recombinant expression construct for regulated high-level production of polypeptides in yeast
WO2011075686A2 (en) * 2009-12-18 2011-06-23 Ventria Bioscience Methods & compositions comprising heat shock proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A response of protein synthesis to temperature shift in the yeast Saccharomyces cerevisiae;MILLE MJ.等;《PNAS》;19790726;全文 *

Also Published As

Publication number Publication date
TWI636136B (zh) 2018-09-21
TW201512401A (zh) 2015-04-01
WO2014145650A1 (en) 2014-09-18
EP3597664A2 (en) 2020-01-22
ES3057435T3 (en) 2026-03-02
EP2971037A1 (en) 2016-01-20
US10138294B2 (en) 2018-11-27
US11447540B2 (en) 2022-09-20
US20160039911A1 (en) 2016-02-11
MX366647B (es) 2019-07-17
EP3597664C0 (en) 2025-11-26
EP2971037B1 (en) 2019-07-10
JP2016516412A (ja) 2016-06-09
SG11201506034TA (en) 2015-09-29
EP3597664B1 (en) 2025-11-26
IL241176A0 (en) 2015-11-30
MX2015011968A (es) 2017-01-06
CA2905180A1 (en) 2014-09-18
MX384491B (es) 2025-03-14
US20190119360A1 (en) 2019-04-25
AU2014232813B2 (en) 2017-12-07
AU2014232813A1 (en) 2015-09-03
CN105121652A (zh) 2015-12-02
NZ711400A (en) 2021-05-28
CA2905180C (en) 2023-03-07
DK2971037T3 (da) 2019-10-14
ES2749751T3 (es) 2020-03-23
EP2971037A4 (en) 2016-07-20
EP3597664A3 (en) 2020-03-11
MX2019008417A (es) 2019-09-13
KR20150140678A (ko) 2015-12-16
KR102202477B1 (ko) 2021-01-13
ZA201505483B (en) 2022-08-31
IL241176B (en) 2020-05-31
JP6412552B2 (ja) 2018-10-24

Similar Documents

Publication Publication Date Title
CN105121652B (zh) 用于在酵母和其它转化细胞中高产量表达多肽的温度变动法
US11225667B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
EP2744903B1 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
US12077794B2 (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
HK40020901A (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
HK40020901B (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
NZ711400B2 (en) Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
NZ621199B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris
NZ721102B2 (en) Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Washington, DC

Patentee after: Lundbeck Seattle biopharmaceutical Co.

Address before: Washington, DC

Patentee before: ALDER BIOPHARMACEUTICALS, Inc.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210809

Address after: Tanba Goro haro

Patentee after: H. LUNDBECK A/S

Address before: Washington, DC

Patentee before: Lundbeck Seattle biopharmaceutical Co.

CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: DanMai Val Be

Patentee after: H. LUNDBECK A/S

Address before: Tanba Goro haro

Patentee before: H. LUNDBECK A/S